{
     "PMID": "18347331",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20080422",
     "LR": "20161124",
     "IS": "1091-6490 (Electronic) 0027-8424 (Linking)",
     "VI": "105",
     "IP": "12",
     "DP": "2008 Mar 25",
     "TI": "Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons.",
     "PG": "4892-7",
     "LID": "10.1073/pnas.0800628105 [doi]",
     "AB": "Transient forebrain or global ischemia induces delayed neuronal death in vulnerable CA1 pyramidal cells with many features of apoptosis. A brief period of ischemia, i.e., ischemic preconditioning, affords robust protection of CA1 neurons against a subsequent more prolonged ischemic challenge. Here we show that preconditioning acts via PI3K/Akt signaling to block the ischemia-induced cascade involving mitochondrial translocation of Bad, assembly of Bad with Bcl-x(L), cleavage of Bcl-x(L) to form its prodeath fragment, DeltaN-Bcl-x(L), activation of large-conductance channels in the mitochondrial outer membrane, mitochondrial release of cytochrome c and Smac/DIABLO (second mitochondria-derived activator of caspases/direct IAP-binding protein with low pI), caspase activation, and neuronal death. These findings show how preconditioning acts to prevent the release of cytochrome c and Smac/DIABLO from mitochondria and to preserve the integrity of the mitochondrial membrane. The specific PI3K inhibitor LY294002 administered in vivo 1 h before or immediately after ischemia or up to 120 h later significantly reverses preconditioning-induced protection, indicating a requirement for sustained PI3K signaling in ischemic tolerance. These findings implicate PI3K/Akt signaling in maintenance of the integrity of the mitochondrial outer membrane.",
     "FAU": [
          "Miyawaki, Takahiro",
          "Mashiko, Toshihiro",
          "Ofengeim, Dimitry",
          "Flannery, Richard J",
          "Noh, Kyung-Min",
          "Fujisawa, Sho",
          "Bonanni, Laura",
          "Bennett, Michael V L",
          "Zukin, R Suzanne",
          "Jonas, Elizabeth A"
     ],
     "AU": [
          "Miyawaki T",
          "Mashiko T",
          "Ofengeim D",
          "Flannery RJ",
          "Noh KM",
          "Fujisawa S",
          "Bonanni L",
          "Bennett MV",
          "Zukin RS",
          "Jonas EA"
     ],
     "AD": "Dominick P. Purpura Department of Neuroscience, Rose F. Kennedy Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 NS046742/NS/NINDS NIH HHS/United States",
          "R01 NS064967/NS/NINDS NIH HHS/United States",
          "NS45693/NS/NINDS NIH HHS/United States",
          "NS45287/NS/NINDS NIH HHS/United States",
          "R01 NS045287/NS/NINDS NIH HHS/United States",
          "R01 NS037402/NS/NINDS NIH HHS/United States",
          "NS37402/NS/NINDS NIH HHS/United States",
          "NS46742/NS/NINDS NIH HHS/United States",
          "R01 NS045876/NS/NINDS NIH HHS/United States",
          "R01 NS045693/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20080317",
     "PL": "United States",
     "TA": "Proc Natl Acad Sci U S A",
     "JT": "Proceedings of the National Academy of Sciences of the United States of America",
     "JID": "7505876",
     "RN": [
          "0 (Caspase Inhibitors)",
          "0 (Chromones)",
          "0 (Large-Conductance Calcium-Activated Potassium Channels)",
          "0 (Morpholines)",
          "0 (bcl-Associated Death Protein)",
          "0 (bcl-X Protein)",
          "31M2U1DVID (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one)",
          "EC 2.7.1.- (Phosphatidylinositol 3-Kinases)",
          "EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)"
     ],
     "SB": "IM",
     "EIN": [
          "Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16855-7"
     ],
     "MH": [
          "Animals",
          "Apoptosis/drug effects",
          "Brain Ischemia/enzymology",
          "Caspase Inhibitors",
          "Chromones/pharmacology",
          "Hippocampus/cytology/drug effects/enzymology/*metabolism",
          "Ion Channel Gating/drug effects",
          "*Ischemic Preconditioning",
          "Large-Conductance Calcium-Activated Potassium Channels/*metabolism",
          "Male",
          "Mitochondria/drug effects/enzymology/*metabolism/secretion",
          "Morpholines/pharmacology",
          "Neurons/cytology/drug effects/enzymology/*metabolism",
          "Phosphatidylinositol 3-Kinases/antagonists & inhibitors",
          "Phosphorylation/drug effects",
          "Protein Transport/drug effects",
          "Proto-Oncogene Proteins c-akt/metabolism",
          "Rats",
          "Rats, Sprague-Dawley",
          "Signal Transduction/drug effects",
          "bcl-Associated Death Protein/*metabolism",
          "bcl-X Protein/*metabolism"
     ],
     "PMC": "PMC2290755",
     "EDAT": "2008/03/19 09:00",
     "MHDA": "2008/04/23 09:00",
     "CRDT": [
          "2008/03/19 09:00"
     ],
     "PHST": [
          "2008/03/19 09:00 [pubmed]",
          "2008/04/23 09:00 [medline]",
          "2008/03/19 09:00 [entrez]"
     ],
     "AID": [
          "0800628105 [pii]",
          "10.1073/pnas.0800628105 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4892-7. doi: 10.1073/pnas.0800628105. Epub 2008 Mar 17.",
     "term": "hippocampus"
}